Table 1 Baseline characteristics of all patients (n = 570)
Characteristics | Cases (n = 570) | Percentage (%) |
|---|---|---|
Age (years) (Mean ± SD) | 51.43 ± 13.52 | |
BMI (Mean ± SD) | 23.57 ± 3.59 | |
Gender | ||
 Male | 382 | 67.00 |
 Female | 188 | 33.00 |
Pathological types | ||
 Clear cell carcinoma | 451 | 79.10 |
 Papillary carcinoma | 41 | 7.20 |
 Others | 78 | 13.70 |
Fuhrman-grade | ||
 I | 119 | 20.90 |
 II | 249 | 43.70 |
 III | 60 | 10.50 |
 IV | 7 | 1.20 |
 Unknown | 135 | 23.70 |
pTNM stage | ||
 I | 397 | 69.60 |
 II | 85 | 14.90 |
 III | 59 | 10.40 |
 IV | 29 | 5.10 |
pT status | ||
 T1 | 407 | 71.40 |
 T2 | 94 | 16.50 |
 T3+ T4 | 69 | 12.10 |
pN status | Â | Â |
 N0 | 535 | 93.90 |
 N1 | 35 | 6.10 |
pM status | ||
 M0 | 550 | 96.50 |
 M1 | 20 | 3.50 |
Urine protein | ||
 No | 460 | 80.70 |
 Yes | 28 | 4.90 |
 Unknown | 82 | 14.40 |
ALP | ||
 Normal | 525 | 92.10 |
 Elevated | 45 | 7.90 |
LDH | ||
 Normal | 468 | 82.10 |
 Elevated | 102 | 17.90 |
CRE | ||
 Normal | 546 | 95.80 |
 Elevated | 24 | 4.20 |
UA | ||
 Normal | 461 | 80.90 |
 Elevated | 109 | 19.10 |
Total protein | ||
 Normal | 503 | 88.20 |
 Elevated | 67 | 11.80 |
Serum globulin | ||
 Normal | 360 | 63.20 |
 Elevated | 210 | 36.80 |
NLR | ||
 < 1.85 | 242 | 42.50 |
  ≥ 1.85 | 328 | 57.50 |
PLR | ||
 < 153 | 418 | 73.30 |
  ≥ 153 | 152 | 26.70 |
CRP/Alb | ||
 < 0.08 | 393 | 68.90 |
  ≥ 0.08 | 177 | 31.10 |